Investments (Details Narrative) - USD ($)							3 Months Ended	12 Months Ended
	Apr. 07, 2022	Apr. 06, 2022	Mar. 03, 2022	Jan. 24, 2022	Oct. 04, 2021	Jul. 31, 2021	Mar. 31, 2022	Dec. 31, 2022		Dec. 31, 2021	Dec. 31, 2019	Mar. 31, 2023		Feb. 28, 2023	Jun. 28, 2021
Stock issued for acquisitions, value							$ 700,000
Share Price														$ 0.0005
Investment								$ 140,006				$ 466,832
Common Stock [Member]
Stock issued for acquisitions, value
GenBio Inc [Member]
Share Price					$ 1
Value of shares invested	$ 7,500	$ 7,500	$ 10,000	$ 15,000	$ 25,000			$ 40,000
Number of shares issued for consideration	7,500	7,500	10,000	15,000	25,000			40,000
Share price								$ 1
GenBio Inc [Member] | Common Stock [Member]
Number of shares issued for consideration					25,000
Preferred Class B [Member]
Share price												$ 0.50
Peer to Peer Inc [Member]
Stock issued for acquisitions, shares											210,000,000
Share price											$ 0.0023
Stock issued for acquisitions, value											$ 483,000
Share Price								$ 0.00020		$ 0.00030
Investment								$ 42,000		$ 63,000
Peer to Peer Inc [Member] | Preferred Class B [Member]
Number of shares issued during period											400,000
Kanab Corp [Member]
Number of shares issued during period										1,000,000
Stock issued for acquisitions, shares											1,000,000
Share price											$ 0.0122
Stock issued for acquisitions, value											$ 12,220
Himalaya Technologies Inc [Member]
Number of shares issued during period						150,000
Share Price								$ 0.08	[1]			$ 0.08	[2]
Investment								$ 12,000	[1]			$ 270,000	[2]
Warrants issued										50,000,000					50,000,000
Warrants term										5 years					5 years
Warrants exercise price										$ 0.0001					$ 0.0001
Valuation of series B preferred stock											$ 270,000	$ 89,826

[1] during 2021, the Company exchanged 1,000,000 shares of KANAB CORP. for 150,000 shares of Series B, preferred stock in HMLA. During 2021, a subsidiary of the Company also received 50,000,000 warrants with a five-year expiration and $.0001 exercise price of HMLA. The Company’s CEO is also the CEO of HMLA.

[2] during 2021, the Company exchanged 1,000,000 shares of KANAB CORP. for 150,000 shares of Series B, preferred stock in HMLA. During 2021, a subsidiary of the Company also received 50,000,000 warrants with a five-year expiration and $.0001 exercise price of HMLA. The Company’s CEO is also the CEO of HMLA.